The list below includes genes that are currently being used to make drug therapy decisions for patients on the St. Jude PG4KDS study.
- Calcium Voltage-Gated Channel subunit alpha 1S (CACNA1S)
- Cytochrome P450 2B6 (CYP2B6)
- Cytochrome P450 2C19 (CYP2C19)
- Cytochrome P450 2C9 (CYP2C9)
- Cytochrome P450 2D6 (CYP2D6)
- Cytochrome P450 3A5 (CYP3A5)
- Dihydropyrimidine Dehydrogenase (DPYD)
- Glucose-6-Phosphate Dehydrogenase (G6PD)
- Mitochondrially Encoded 12S RNA (mt-RNR1)
- Ryanodine Receptor Isoform 1 (RYR1)
- SLCO1B1
- Thiopurine Methyltransferase (TPMT)
- Uridine Diphosphate Glucuronosyltransferase 1A1 (UGT1A1)